![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() by AFP Staff Writers Beijing (AFP) March 23, 2021
China's drug authority has approved for clinical trials an inhaled Covid-19 vaccine co-developed by domestic firm CanSino Biologics, the company said in a filing on Tuesday. The move comes after the National Medical Products Administration gave another CanSino vaccine conditional approval last month, allowing it for public use. China currently has five coronavirus vaccines that have been given conditional market approval or allowed for emergency use, but none of these are administered by inhalation. CanSino said in its latest filing on the Hong Kong stock exchange that the vaccine for inhalation was jointly developed by the company and the Beijing Institute of Biotechnology, adding that their clinical trial application got the green light on Monday. But it warned that the vaccine's safety and efficacy remain "subject to confirmation" in trials. As of March 20, China had administered 74.96 million coronavirus vaccine doses, according to Our World in Data, a collaboration between Oxford University and a charity. Chinese embassies in some countries including the United States, Australia and India have issued notices saying the country will open visa applications to select people who have taken a China-made jab. On Tuesday, a Chinese foreign ministry official said it is in "close communication" with various countries and "willing to reach mutually beneficial arrangements" to facilitate cross-border travel. bys/axn
![]() ![]() G7 finance ministers discuss Covid aid for poor London (AFP) March 19, 2021 Britain on Friday hosts an online gathering of G7 finance ministers, with discussions focusing on aid for the poorest nations hit by the pandemic. Finance minister Rishi Sunak is hosting counterparts from Canada, France, Germany, Italy, Japan and the United States for the meeting, held online owing to Covid-19. The gathering, which began at 1200 GMT and is expected to last several hours, follows a similar event in February and comes before a G7 summit in Britain later this year. Ahead of Fri ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |